Adding insulin to oral antidiabetes drugs does not up CVD events

03/14/2012 | Medscape (free registration)

Data on nearly 15,000 type 2 diabetes patients revealed the odds ratio for macrovascular events associated with insulin therapy was only 0.53 in those who took one oral glucose-lowering drug, 0.85 in those who took two and 1.07 in those who took three. The findings suggest that using insulin as an add-on to OGLD treatment may not increase the incidence of cardiovascular events, researchers reported in Pharmacoepidemiology and Drug Safety.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC